BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24886204)

  • 1. Tumor loci and their interactions on mouse chromosome 19 that contribute to testicular germ cell tumors.
    Zhu R; Matin A
    BMC Genet; 2014 May; 15():65. PubMed ID: 24886204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications.
    Youngren KK; Nadeau JH; Matin A
    Hum Mol Genet; 2003 Feb; 12(4):389-98. PubMed ID: 12566386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular germ cell tumors in mice: new ways to study a genetically complex trait.
    Heaney JD; Nadeau JH
    Methods Mol Biol; 2008; 450():211-31. PubMed ID: 18370062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.
    Zhu R; Ji Y; Xiao L; Matin A
    Mamm Genome; 2007 Aug; 18(8):584-95. PubMed ID: 17671812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of splicing factor 1 suppresses the occurrence of testicular germ cell tumors.
    Zhu R; Heaney J; Nadeau JH; Ali S; Matin A
    Cancer Res; 2010 Sep; 70(18):7264-72. PubMed ID: 20736371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors on mouse chromosome 18 affecting susceptibility to testicular germ cell tumors and permissiveness to embryonic stem cell derivation.
    Anderson PD; Nelson VR; Tesar PJ; Nadeau JH
    Cancer Res; 2009 Dec; 69(23):9112-7. PubMed ID: 19934337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain.
    Matin A; Collin GB; Asada Y; Varnum D; Nadeau JH
    Nat Genet; 1999 Oct; 23(2):237-40. PubMed ID: 10508525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the mouse y chromosome on susceptibility to testicular germ cell tumors.
    Anderson PD; Lam MY; Poirier C; Bishop CE; Nadeau JH
    Cancer Res; 2009 Apr; 69(8):3614-8. PubMed ID: 19351821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23.
    Schumacher FR; Wang Z; Skotheim RI; Koster R; Chung CC; Hildebrandt MA; Kratz CP; Bakken AC; Bishop DT; Cook MB; Erickson RL; Fosså SD; Greene MH; Jacobs KB; Kanetsky PA; Kolonel LN; Loud JT; Korde LA; Le Marchand L; Lewinger JP; Lothe RA; Pike MC; Rahman N; Rubertone MV; Schwartz SM; Siegmund KD; Skinner EC; Turnbull C; Van Den Berg DJ; Wu X; Yeager M; Nathanson KL; Chanock SJ; Cortessis VK; McGlynn KA
    Hum Mol Genet; 2013 Jul; 22(13):2748-53. PubMed ID: 23462292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphisms of KITLG, SPRY4, and BAK1 genes in patients with testicular germ cell tumors and individuals with infertility associated with AZFc deletion of the Y chromosome].
    Nemtsova MV; Ivkin EV; Simonova OA; Rudenko VV; Chernykh VB; Mikhaylenko DS; Loran OB
    Mol Biol (Mosk); 2016; 50(6):960-967. PubMed ID: 28064312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.
    Pathak A; Adams CD; Loud JT; Nichols K; Stewart DR; Greene MH
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1614-21. PubMed ID: 26265202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What leads from dead-end?
    Matin A
    Cell Mol Life Sci; 2007 Jun; 64(11):1317-22. PubMed ID: 17464447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular germ cell tumor: a comprehensive review.
    Batool A; Karimi N; Wu XN; Chen SR; Liu YX
    Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.
    Giambartolomei C; Mueller CM; Greene MH; Korde LA
    Cancer Epidemiol; 2009 Jul; 33(1):31-6. PubMed ID: 19679044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice.
    Lam MY; Youngren KK; Nadeau JH
    Genetics; 2004 Feb; 166(2):925-33. PubMed ID: 15020477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice.
    Heaney JD; Lam MY; Michelson MV; Nadeau JH
    Cancer Res; 2008 Jul; 68(13):5193-7. PubMed ID: 18593919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability.
    Nelson VR; Heaney JD; Tesar PJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2766-73. PubMed ID: 22923694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.
    Litchfield K; Levy M; Orlando G; Loveday C; Law PJ; Migliorini G; Holroyd A; Broderick P; Karlsson R; Haugen TB; Kristiansen W; Nsengimana J; Fenwick K; Assiotis I; Kote-Jarai Z; Dunning AM; Muir K; Peto J; Eeles R; Easton DF; Dudakia D; Orr N; Pashayan N; ; ; Bishop DT; Reid A; Huddart RA; Shipley J; Grotmol T; Wiklund F; Houlston RS; Turnbull C
    Nat Genet; 2017 Jul; 49(7):1133-1140. PubMed ID: 28604728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.
    Youngren KK; Coveney D; Peng X; Bhattacharya C; Schmidt LS; Nickerson ML; Lamb BT; Deng JM; Behringer RR; Capel B; Rubin EM; Nadeau JH; Matin A
    Nature; 2005 May; 435(7040):360-4. PubMed ID: 15902260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
    Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
    Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.